Clinical Trials Browser

Phase EARLY_PHASE1 × Magnetic Resonance Spectroscopy × 1 year × Clear all

NCT03422731 2026-03-16

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05800405 2026-02-04

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT07025226 2026-01-26

Senolytics

Phase EARLY_PHASE1 Recruiting

Glioma

NCT05851378 2026-01-12

Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

Phase EARLY_PHASE1 Recruiting

Glioma

NCT04040088 2026-01-08

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Phase EARLY_PHASE1 Active not recruiting

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

NCT07261657 2025-12-03

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT05045027 2025-11-14

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

Phase EARLY_PHASE1 Active not recruiting

Glioma

NCT05717153 2025-11-04

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

Phase EARLY_PHASE1 Recruiting

Glioma

NCT05047965 2025-11-03

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT03276832 2025-10-28

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Phase EARLY_PHASE1 Completed

Melanoma

NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

Phase EARLY_PHASE1 Recruiting

Neuroendocrine Tumors

NCT06328686 2025-09-17

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

Phase EARLY_PHASE1 Recruiting

Brain Neoplasms, Neoplasm Metastasis

NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Phase EARLY_PHASE1 Completed

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

NCT03039413 2025-08-22

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Phase EARLY_PHASE1 Completed

Carcinoma, Transitional Cell

NCT04147494 2025-08-12

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Phase EARLY_PHASE1 Active not recruiting

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT04457258 2025-08-12

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

Phase EARLY_PHASE1 Active not recruiting

Sarcoma

NCT07089940 2025-07-29

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04581382 2025-07-10

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

Phase EARLY_PHASE1 Completed

Melanoma

NCT05852041 2025-05-22

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT05851365 2025-05-08

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms